FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893577428> ?p ?o ?g. }

• W2893577428 endingPage "443" @default.
• W2893577428 startingPage "436" @default.
• W2893577428 abstract "BackgroundWe investigated the frequency of c-MYC amplification in esophageal squamous cell carcinoma (ESCC), including both stage I to II and III to IVa disease, and evaluated the correlation of c-MYC amplification with clinicopathologic variables and outcome.MethodsIn 259 ESCCs resected at Zhongshan Hospital, Fudan University, from January 2007 to November 2010, c-MYC amplification was analyzed by using tissue microarray, with fluorescence in situ hybridization assay.Resultsc-MYC gene amplification was found in 43.2% (112 of 259) of patients with ESCC. Significant differences were found between c-MYC amplification and patient age (p = 0.009) and lymph node metastasis (p = 0.046). The median follow-up period was 33 months (range: 4 to 102 months). A survival difference was found between patients with different c-MYC status. Among 112 patients with c-MYC amplification, a significantly poorer prognosis was observed, with a median disease-free survival (DFS) and overall survival (OS) of 24.0 and 31.0 months compared with 48.0 and 48.0 months, respectively, for patients without c-MYC amplification (p = 0.011 and 0.018). On univariate and multivariate analysis, site, clinical stage, lymph node metastasis, adjuvant therapy, and c-MYC amplification were associated with DFS and OS. When patients were divided into stage I to II and stage III to IV subgroups, c-MYC amplification tended to associate with poorer survival but without statistical difference (p > 0.05).Conclusionsc-MYC amplification was associated with age and lymph node metastasis and was an independent poor-prognostic factor for DFS and OS in the full cohort of patients with ESCC. We investigated the frequency of c-MYC amplification in esophageal squamous cell carcinoma (ESCC), including both stage I to II and III to IVa disease, and evaluated the correlation of c-MYC amplification with clinicopathologic variables and outcome. In 259 ESCCs resected at Zhongshan Hospital, Fudan University, from January 2007 to November 2010, c-MYC amplification was analyzed by using tissue microarray, with fluorescence in situ hybridization assay. c-MYC gene amplification was found in 43.2% (112 of 259) of patients with ESCC. Significant differences were found between c-MYC amplification and patient age (p = 0.009) and lymph node metastasis (p = 0.046). The median follow-up period was 33 months (range: 4 to 102 months). A survival difference was found between patients with different c-MYC status. Among 112 patients with c-MYC amplification, a significantly poorer prognosis was observed, with a median disease-free survival (DFS) and overall survival (OS) of 24.0 and 31.0 months compared with 48.0 and 48.0 months, respectively, for patients without c-MYC amplification (p = 0.011 and 0.018). On univariate and multivariate analysis, site, clinical stage, lymph node metastasis, adjuvant therapy, and c-MYC amplification were associated with DFS and OS. When patients were divided into stage I to II and stage III to IV subgroups, c-MYC amplification tended to associate with poorer survival but without statistical difference (p > 0.05). c-MYC amplification was associated with age and lymph node metastasis and was an independent poor-prognostic factor for DFS and OS in the full cohort of patients with ESCC." @default.
• W2893577428 created "2018-10-05" @default.
• W2893577428 creator A5000689771 @default.
• W2893577428 creator A5000952365 @default.
• W2893577428 creator A5013134577 @default.
• W2893577428 creator A5018872547 @default.
• W2893577428 creator A5021032300 @default.
• W2893577428 creator A5022092259 @default.
• W2893577428 creator A5029732076 @default.
• W2893577428 creator A5030535403 @default.
• W2893577428 creator A5080102032 @default.
• W2893577428 creator A5091642305 @default.
• W2893577428 date "2019-02-01" @default.
• W2893577428 modified "2023-10-14" @default.
• W2893577428 title "Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma" @default.
• W2893577428 cites W1484187172 @default.
• W2893577428 cites W1491517465 @default.
• W2893577428 cites W1529982641 @default.
• W2893577428 cites W1974915759 @default.
• W2893577428 cites W1979466366 @default.
• W2893577428 cites W1992073257 @default.
• W2893577428 cites W2000255249 @default.
• W2893577428 cites W2020534880 @default.
• W2893577428 cites W2031385304 @default.
• W2893577428 cites W2054606083 @default.
• W2893577428 cites W2057235806 @default.
• W2893577428 cites W2071193240 @default.
• W2893577428 cites W2097774235 @default.
• W2893577428 cites W2101979288 @default.
• W2893577428 cites W2105061544 @default.
• W2893577428 cites W2120326504 @default.
• W2893577428 cites W2129138183 @default.
• W2893577428 cites W2153056550 @default.
• W2893577428 cites W2197459376 @default.
• W2893577428 cites W2257503101 @default.
• W2893577428 cites W2265032271 @default.
• W2893577428 cites W2272678892 @default.
• W2893577428 cites W2272984102 @default.
• W2893577428 cites W2293357755 @default.
• W2893577428 cites W2327517543 @default.
• W2893577428 cites W2556334837 @default.
• W2893577428 cites W2560479877 @default.
• W2893577428 cites W2570401594 @default.
• W2893577428 cites W2603997054 @default.
• W2893577428 cites W2735791491 @default.
• W2893577428 cites W4211048478 @default.
• W2893577428 cites W4249441028 @default.
• W2893577428 doi "https://doi.org/10.1016/j.athoracsur.2018.07.077" @default.
• W2893577428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30273571" @default.
• W2893577428 hasPublicationYear "2019" @default.
• W2893577428 type Work @default.
• W2893577428 sameAs 2893577428 @default.
• W2893577428 citedByCount "14" @default.
• W2893577428 countsByYear W28935774282020 @default.
• W2893577428 countsByYear W28935774282021 @default.
• W2893577428 countsByYear W28935774282022 @default.
• W2893577428 countsByYear W28935774282023 @default.
• W2893577428 crossrefType "journal-article" @default.
• W2893577428 hasAuthorship W2893577428A5000689771 @default.
• W2893577428 hasAuthorship W2893577428A5000952365 @default.
• W2893577428 hasAuthorship W2893577428A5013134577 @default.
• W2893577428 hasAuthorship W2893577428A5018872547 @default.
• W2893577428 hasAuthorship W2893577428A5021032300 @default.
• W2893577428 hasAuthorship W2893577428A5022092259 @default.
• W2893577428 hasAuthorship W2893577428A5029732076 @default.
• W2893577428 hasAuthorship W2893577428A5030535403 @default.
• W2893577428 hasAuthorship W2893577428A5080102032 @default.
• W2893577428 hasAuthorship W2893577428A5091642305 @default.
• W2893577428 hasConcept C121608353 @default.
• W2893577428 hasConcept C126322002 @default.
• W2893577428 hasConcept C142724271 @default.
• W2893577428 hasConcept C143998085 @default.
• W2893577428 hasConcept C144301174 @default.
• W2893577428 hasConcept C146357865 @default.
• W2893577428 hasConcept C151730666 @default.
• W2893577428 hasConcept C2777546739 @default.
• W2893577428 hasConcept C2779013556 @default.
• W2893577428 hasConcept C2780849966 @default.
• W2893577428 hasConcept C2994415158 @default.
• W2893577428 hasConcept C38180746 @default.
• W2893577428 hasConcept C71924100 @default.
• W2893577428 hasConcept C86803240 @default.
• W2893577428 hasConcept C90924648 @default.
• W2893577428 hasConceptScore W2893577428C121608353 @default.
• W2893577428 hasConceptScore W2893577428C126322002 @default.
• W2893577428 hasConceptScore W2893577428C142724271 @default.
• W2893577428 hasConceptScore W2893577428C143998085 @default.
• W2893577428 hasConceptScore W2893577428C144301174 @default.
• W2893577428 hasConceptScore W2893577428C146357865 @default.
• W2893577428 hasConceptScore W2893577428C151730666 @default.
• W2893577428 hasConceptScore W2893577428C2777546739 @default.
• W2893577428 hasConceptScore W2893577428C2779013556 @default.
• W2893577428 hasConceptScore W2893577428C2780849966 @default.
• W2893577428 hasConceptScore W2893577428C2994415158 @default.
• W2893577428 hasConceptScore W2893577428C38180746 @default.
• W2893577428 hasConceptScore W2893577428C71924100 @default.
• W2893577428 hasConceptScore W2893577428C86803240 @default.
• W2893577428 hasConceptScore W2893577428C90924648 @default.

• next